These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients. Araki R; Yukawa E; Nakashima MN; Fukuchi H; Sasaki H; Yano K; Nakashima M Ther Drug Monit; 2011 Dec; 33(6):750-6. PubMed ID: 22105593 [TBL] [Abstract][Full Text] [Related]
5. Disposition of intravenous amiodarone in subjects with normal and impaired renal function. Ujhelyi MR; Klamerus KJ; Vadiei K; O'Rangers E; Izard M; Neefe DL; Zimmerman JJ; Chow MS J Clin Pharmacol; 1996 Feb; 36(2):122-30. PubMed ID: 8852388 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of intravenous amiodarone in patients with refractory ventricular tachycardia/fibrillation. Korth-Bradley JM; Rose GM; de Vane PJ; Peters J; Chiang ST J Clin Pharmacol; 1996 Aug; 36(8):715-9. PubMed ID: 8877675 [TBL] [Abstract][Full Text] [Related]
7. [Amiodarone absorption and elimination after oral and intravenous administration in healthy individuals]. Gaete LE; Ortiz M; Soto J; Saavedra I Rev Med Chil; 1995 Jun; 123(6):713-9. PubMed ID: 8525224 [TBL] [Abstract][Full Text] [Related]
8. Effect of obesity on serum amiodarone concentration in Japanese patients: population pharmacokinetic investigation by multiple trough screen analysis. Fukuchi H; Nakashima M; Araki R; Komiya N; Hayano M; Yano K; Sasaki H; Yukawa E J Clin Pharm Ther; 2009 Jun; 34(3):329-36. PubMed ID: 19646079 [TBL] [Abstract][Full Text] [Related]
9. Amiodarone concentration in human myocardium after rapid intravenous administration. Anastasiou-Nana MI; Nanas JN; Alexopoulos G; Karli JN; Margari ZJ; Agapitos E; Patsi EN; Stamatelopoulos SF Cardiovasc Drugs Ther; 1999 May; 13(3):265-70. PubMed ID: 10439890 [TBL] [Abstract][Full Text] [Related]
10. Population modelling to describe pharmacokinetics of amiodarone in rats: relevance of plasma protein and tissue depot binding. Campos Moreno E; Merino Sanjuán M; Merino V; Nácher A; Martín Algarra RV; Casabó VG Eur J Pharm Sci; 2007 Feb; 30(2):190-7. PubMed ID: 17218087 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses. De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906 [TBL] [Abstract][Full Text] [Related]
12. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use. Chow MS Ann Pharmacother; 1996 Jun; 30(6):637-43. PubMed ID: 8792951 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects. Shiga T; Tanaka T; Irie S; Hagiwara N; Kasanuki H Heart Vessels; 2011 May; 26(3):274-81. PubMed ID: 21052689 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population. Kashima A; Funahashi M; Fukumoto K; Komamura K; Kamakura S; Kitakaze M; Ueno K Biol Pharm Bull; 2005 Oct; 28(10):1934-8. PubMed ID: 16204949 [TBL] [Abstract][Full Text] [Related]
15. [Amiodarone administered orally or intravenously - the same or different drug?]. Kosior DA; Krzykwa A; Postuła M Pol Merkur Lekarski; 2013 Apr; 34(202):183-7. PubMed ID: 23745321 [TBL] [Abstract][Full Text] [Related]
17. Use of population modeling to define rational monitoring of amiodarone hepatic effects. Pollak PT; Shafer SL Clin Pharmacol Ther; 2004 Apr; 75(4):342-51. PubMed ID: 15060512 [TBL] [Abstract][Full Text] [Related]
18. A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data. Lu JT; Cai Y; Chen F; Jia WW; Hu ZY; Zhao YS Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):689-703. PubMed ID: 26254911 [TBL] [Abstract][Full Text] [Related]
19. Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias. Salem JE; El-Aissaoui M; Alazard M; Hulot JS; Aissaoui N; Le-Heuzey JY; Funck-Brentano C; Faisy C; Urien S Clin Pharmacokinet; 2016 Aug; 55(8):991-1002. PubMed ID: 26946135 [TBL] [Abstract][Full Text] [Related]
20. Physiologically based pharmacokinetic modeling to predict drug-drug interactions involving inhibitory metabolite: a case study of amiodarone. Chen Y; Mao J; Hop CE Drug Metab Dispos; 2015 Feb; 43(2):182-9. PubMed ID: 25324279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]